[go: up one dir, main page]

AU2008903115A0 - Pharmaceutical Formulation - Google Patents

Pharmaceutical Formulation

Info

Publication number
AU2008903115A0
AU2008903115A0 AU2008903115A AU2008903115A AU2008903115A0 AU 2008903115 A0 AU2008903115 A0 AU 2008903115A0 AU 2008903115 A AU2008903115 A AU 2008903115A AU 2008903115 A AU2008903115 A AU 2008903115A AU 2008903115 A0 AU2008903115 A0 AU 2008903115A0
Authority
AU
Australia
Prior art keywords
pharmaceutical formulation
formulation
pharmaceutical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2008903115A
Inventor
Panagiotis Keramidas
Brett A. Mooney
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Alphapharm Pty Ltd
Original Assignee
Alphapharm Pty Ltd
Filing date
Publication date
Application filed by Alphapharm Pty Ltd filed Critical Alphapharm Pty Ltd
Publication of AU2008903115A0 publication Critical patent/AU2008903115A0/en
Priority to US13/000,291 priority Critical patent/US8618157B2/en
Priority to CN200980126624.5A priority patent/CN102088966B/en
Priority to CA2765866A priority patent/CA2765866C/en
Priority to PCT/AU2009/000132 priority patent/WO2009152551A1/en
Priority to EP09765240A priority patent/EP2306998A4/en
Priority to AU2009260166A priority patent/AU2009260166B2/en
Abandoned legal-status Critical Current

Links

AU2008903115A 2008-06-20 2008-06-20 Pharmaceutical Formulation Abandoned AU2008903115A0 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
US13/000,291 US8618157B2 (en) 2008-06-20 2009-02-04 Pharmaceutical formulation
CN200980126624.5A CN102088966B (en) 2008-06-20 2009-02-04 Pharmaceutical formulation
CA2765866A CA2765866C (en) 2008-06-20 2009-02-04 Single phase pharmaceutical composition of a 5-ht1 inhibitor and an nsaid
PCT/AU2009/000132 WO2009152551A1 (en) 2008-06-20 2009-02-04 Pharmaceutical formulation
EP09765240A EP2306998A4 (en) 2008-06-20 2009-02-04 PHARMACEUTICAL FORMULATION
AU2009260166A AU2009260166B2 (en) 2008-06-20 2009-02-04 Pharmaceutical formulation

Publications (1)

Publication Number Publication Date
AU2008903115A0 true AU2008903115A0 (en) 2008-07-03

Family

ID=

Similar Documents

Publication Publication Date Title
HUS1800043I1 (en) Pharmaceutical formulation 514
GB2450753B (en) New Pharmaceutical formulation
EP2285357B8 (en) Pharmaceutical compositions comprising brivaracetam
EP2281038B8 (en) Protein formulation
IL208788A (en) Solid pharmaceutical formulation
WO2010114629A9 (en) Formulation
GB0614586D0 (en) Pharmaceutical Formulation
AU2008903115A0 (en) Pharmaceutical Formulation
AU2007905870A0 (en) Pharmaceutical formulation
HK1156546A (en) Pharmaceutical composition
HK1150784A (en) Pharmaceutical composition
GB0805292D0 (en) Pharmaceutical formulation
AU2008902052A0 (en) Formulation
AU2008904975A0 (en) Formulation
HK1162994A (en) Pharmaceutical compounds
GB0705030D0 (en) Pharmaceutical formulation
HK1149452A (en) Novel formulation
HK1149191A (en) Pharmaceutical dosage form
AU2006903259A0 (en) Pharmaceutical formulation
HK1156629A (en) Solid pharmaceutical composition
HK1166955A (en) Formulation
AU2007900682A0 (en) Novel Formulation
HK1150753A (en) Solid pharmaceutical dosage form
HK1149514A (en) Imiquimod formulation
HK1143953A (en) Pharmaceutical composition